Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and implantable pacemaker systems used to manage slow or irregular heart rhythms. The company also provides coronary stents, which are used in the treatment of coronary artery disease; and products used to treat patients with atherosclerosis. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty, as well as Apex pre-dilatation balloon catheter. In addition, the company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. Further, it is developing a device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis; and less-invasive medical technologies used treatment of rate and rhythm disorders of the heart. Additionally, the company sells products designed to treat patients with peripheral disease; and products designed to treat patients with non-vascular disease. It also offers a system that is designed to capture embolic material that may become dislodged during a procedure; products to diagnose, treat, and ease various digestive diseases; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; devices to treat various urological and gynecological disorders; products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding; stone management products; and system for the management of chronic pain. The company was founded in 1979 and is headquartered in Natick, Massachusetts.

Sector & Industry Watch List